1. Home
  2. AZTR vs GITS Comparison

AZTR vs GITS Comparison

Compare AZTR & GITS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZTR
  • GITS
  • Stock Information
  • Founded
  • AZTR 2014
  • GITS 2018
  • Country
  • AZTR United States
  • GITS South Korea
  • Employees
  • AZTR N/A
  • GITS N/A
  • Industry
  • AZTR Biotechnology: Pharmaceutical Preparations
  • GITS
  • Sector
  • AZTR Health Care
  • GITS
  • Exchange
  • AZTR Nasdaq
  • GITS Nasdaq
  • Market Cap
  • AZTR 4.0M
  • GITS 4.1M
  • IPO Year
  • AZTR 2023
  • GITS N/A
  • Fundamental
  • Price
  • AZTR $0.22
  • GITS $2.70
  • Analyst Decision
  • AZTR
  • GITS
  • Analyst Count
  • AZTR 0
  • GITS 0
  • Target Price
  • AZTR N/A
  • GITS N/A
  • AVG Volume (30 Days)
  • AZTR 798.9K
  • GITS 2.5M
  • Earning Date
  • AZTR 08-11-2025
  • GITS 08-05-2025
  • Dividend Yield
  • AZTR N/A
  • GITS N/A
  • EPS Growth
  • AZTR N/A
  • GITS N/A
  • EPS
  • AZTR N/A
  • GITS N/A
  • Revenue
  • AZTR $7,500.00
  • GITS N/A
  • Revenue This Year
  • AZTR N/A
  • GITS N/A
  • Revenue Next Year
  • AZTR N/A
  • GITS N/A
  • P/E Ratio
  • AZTR N/A
  • GITS N/A
  • Revenue Growth
  • AZTR N/A
  • GITS N/A
  • 52 Week Low
  • AZTR $0.21
  • GITS $0.87
  • 52 Week High
  • AZTR $1.25
  • GITS $9.78
  • Technical
  • Relative Strength Index (RSI)
  • AZTR 37.04
  • GITS N/A
  • Support Level
  • AZTR $0.22
  • GITS N/A
  • Resistance Level
  • AZTR $0.24
  • GITS N/A
  • Average True Range (ATR)
  • AZTR 0.01
  • GITS 0.00
  • MACD
  • AZTR -0.00
  • GITS 0.00
  • Stochastic Oscillator
  • AZTR 7.97
  • GITS 0.00

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

About GITS Global Interactive Technologies Inc. Common Stock

Global Interactive Technologies Inc, formerly Hanryu Holdings Inc is the creator of the engaging social media platform, FANTOO. Through FANTOO, it provides a multi-media platform for its users to interact with other like-minded users, share their appreciation of various types of entertainment and cultures, create their content, enjoy content, and engage in commerce.

Share on Social Networks: